Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 3,133-3,144 of 10,612

Drug study icon

TerminatedNCT04821271

Antidepressant Effects of TS-161 in Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Depression

Drug study icon

CompletedNCT01670019

Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Duke University
Condition: Depression, Schizophrenia

Drug study icon

TerminatedNCT04697693

Antidepressant Response in Older Adults With Comorbid PTSD and MDD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, DepressionDrugFrom 60 Years to 105 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: PTSD, Depression

Drug study icon

CompletedNCT00395213

Antidepressant Safety in Kids Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCD, Eating disorders, ...DrugFrom 7 Years to 17 Years

Countries: United States
Sponsor: Duke University
Condition: OCD, Eating disorders, ...

Drug study icon

CompletedNCT00641927

Antidepressant Therapy for Bipolar II Major Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugOver 18 Years

Countries: United States
Sponsor: Stanley Medical Research Institute
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT00602537

Antidepressant Therapy in Treating Bipolar Type II Major Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugOver 18 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT00047450

Antidepressant Treatment in Older Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 40 Years

Countries: United States
Sponsor: Veterans Medical Research Foundation
Condition: Schizophrenia

Other study type icon

CompletedNCT00585702

Antimanic Drug Use in Pregnancy

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityObservationalFrom 18 Years to 45 Years

Countries: United States
Sponsor: University of Pittsburgh
Condition: Bipolarity

Behavioral study icon

CompletedNCT04481048

Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDBehavioralFrom 8 Years to 16 Years

Countries: United States
Sponsor: Children's Hospital Medical Center, Cincinnati
Condition: ADHD

Drug study icon

CompletedNCT00417482

Antipsychotic Discontinuation in Alzheimer's Disease

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 50 Years to 95 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Schizophrenia

Drug study icon

TerminatedNCT01621737

Antipsychotic Effects of Oxytocin

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 21 Years

Countries: United States
Sponsor: University of California, San Diego
Condition: Schizophrenia

Drug study icon

TerminatedNCT01913327

Antipsychotic Effects on Brain Function in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 40 Years

Countries: United States
Sponsor: University of California, San Francisco
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.